Cargando…
POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19
Autores principales: | Jhamb, S, Khan, S, Taneja, H, Sachdev, A, Mazumder, D, Buikema, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769600/ http://dx.doi.org/10.1016/j.jval.2021.11.143 |
Ejemplares similares
-
POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients
por: Mozaffari, E, et al.
Publicado: (2022) -
POSB193 COVID-19 Vaccine Development Pipeline: 2021
por: Ahlawat, R, et al.
Publicado: (2022) -
POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19.
por: Santos, A, et al.
Publicado: (2022) -
POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries
por: Davis-Ajami, ML, et al.
Publicado: (2022) -
POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies
por: Net, P, et al.
Publicado: (2022)